Back to Search Start Over

Crosstalk of platelets with macrophages and fibroblasts aggravates inflammation, aortic wall stiffening, and osteopontin release in abdominal aortic aneurysm.

Authors :
Wagenhäuser MU
Mulorz J
Krott KJ
Bosbach A
Feige T
Rhee YH
Chatterjee M
Petzold N
Böddeker C
Ibing W
Krüger I
Popovic AM
Roseman A
Spin JM
Tsao PS
Schelzig H
Elvers M
Source :
Cardiovascular research [Cardiovasc Res] 2024 Mar 30; Vol. 120 (4), pp. 417-432.
Publication Year :
2024

Abstract

Aims: Abdominal aortic aneurysm (AAA) is a highly lethal disease with progressive dilatation of the abdominal aorta accompanied by degradation and remodelling of the vessel wall due to chronic inflammation. Platelets play an important role in cardiovascular diseases, but their role in AAA is poorly understood.<br />Methods and Results: The present study revealed that platelets play a crucial role in promoting AAA through modulation of inflammation and degradation of the extracellular matrix (ECM). They are responsible for the up-regulation of SPP1 (osteopontin, OPN) gene expression in macrophages and aortic tissue, which triggers inflammation and remodelling and also platelet adhesion and migration into the abdominal aortic wall and the intraluminal thrombus (ILT). Further, enhanced platelet activation and pro-coagulant activity result in elevated gene expression of various cytokines, Mmp9 and Col1a1 in macrophages and Il-6 and Mmp9 in fibroblasts. Enhanced platelet activation and pro-coagulant activity were also detected in AAA patients. Further, we detected platelets and OPN in the vessel wall and in the ILT of patients who underwent open repair of AAA. Platelet depletion in experimental murine AAA reduced inflammation and ECM remodelling, with reduced elastin fragmentation and aortic diameter expansion. Of note, OPN co-localized with platelets, suggesting a potential role of OPN for the recruitment of platelets into the ILT and the aortic wall.<br />Conclusion: In conclusion, our data strongly support the potential relevance of anti-platelet therapy to reduce AAA progression and rupture in AAA patients.<br />Competing Interests: Conflict of interest: None declared.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1755-3245
Volume :
120
Issue :
4
Database :
MEDLINE
Journal :
Cardiovascular research
Publication Type :
Academic Journal
Accession number :
37976180
Full Text :
https://doi.org/10.1093/cvr/cvad168